Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.
Sec. Antibiotic Resistance and New Antimicrobial drugs
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1433597
This article is part of the Research Topic Rising Stars in Antibiotic Resistance and New Antimicrobial Drugs View all 5 articles

Assessment of community-acquired urinary tract infections treatment in the emergency department: a retrospective study

Provisionally accepted
Marie Ange Ghaleb Marie Ange Ghaleb Antoine Zoghbi Antoine Zoghbi Zeina Bou Chebl Zeina Bou Chebl Eddy Lilly Eddy Lilly Gebrael Saliba Gebrael Saliba Jacques Choucair Jacques Choucair Racha Ibrahim Racha Ibrahim *
  • Hôtel-Dieu de France, Beirut, Lebanon

The final, formatted version of the article will be published soon.

    Introduction: Urinary tract infection (UTI) is one of the most common medical complaints in the emergency department (ED). The aim of this study was to assess the real indication of an initial broad-spectrum treatment administered in the ED for hospitalized patients with a diagnosis of community-acquired UTI (CAUTI). Materials and methods: This is a monocentric observational retrospective study conducted in the ED of one of the largest tertiary care centers in Lebanon, on a two-year period, including adult patients admitted to the hospital for a CAUTI. The primary outcome was to evaluate the need of downgrading empirical antibiotherapy started in the ED. Secondary outcomes included a description of CAUTIs characteristics: prevalence and risk factors for (extended spectrum beta lactamases) ESBL-related infection, complicated and uncomplicated UTIs, empirical and targeted treatment, and finally the rate of adherence to local guidelines.The most isolated strains on urine cultures were gram negative bacilli (GNB) with 29.1% producing ESBL; 69.4% of patients received an ESBL-targeting empirical treatment in the ED, in agreement with local guidelines, 46% of which needed a downgrade. Amikacin adjunction was only indicated in 42.8% of the cases. Patients who received antibiotics in the last 6 months had a 2.36 times higher risk of developing an ESBL-related infection.This study showed a high adherence rate to local recommendations suggesting the use of empirical ESBL-targeting antibiotherapy even in uncomplicated UTIs. However, the frequent need of de-escalation highlights the importance of establishing an efficient multi-drug resistant (MDR) bacteria surveillance system in the community in order to elaborate a stewardship program with more solid local guidelines.

    Keywords: Urinary tract infection, emergency department, extended spectrum beta-lactamase, Broad spectrum antibiotic, guidelines, Stewardship

    Received: 16 May 2024; Accepted: 13 Aug 2024.

    Copyright: © 2024 Ghaleb, Zoghbi, Bou Chebl, Lilly, Saliba, Choucair and Ibrahim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Racha Ibrahim, Hôtel-Dieu de France, Beirut, Lebanon

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.